Ketlogetswe, K. S., McKibben, R., Jacobson, L. P., Li, X., Dobs, A. S., Budoff, M., . . . Brown, T. T. (2015). Osteoprotegerin (OPG), but not Receptor Activator for Nuclear Factor Kappa B Ligand (RANKL), is Associated with Subclinical Coronary Atherosclerosis in HIV-infected Men. J Acquir Immune Defic Syndr.
Chicago Style CitationKetlogetswe, Kerunne S., et al. "Osteoprotegerin (OPG), but Not Receptor Activator for Nuclear Factor Kappa B Ligand (RANKL), Is Associated With Subclinical Coronary Atherosclerosis in HIV-infected Men." J Acquir Immune Defic Syndr 2015.
Cita MLAKetlogetswe, Kerunne S., et al. "Osteoprotegerin (OPG), but Not Receptor Activator for Nuclear Factor Kappa B Ligand (RANKL), Is Associated With Subclinical Coronary Atherosclerosis in HIV-infected Men." J Acquir Immune Defic Syndr 2015.